CDK13 cooperates with CDK12 to control global RNA polymerase II processivity

Fan, Zheng, Devlin, Jennifer R., Hogg, Simon J., Doyle, Maria A., Harrison, Paul F., Todorovski, Izabela, Cluse, Leonie A., Knight, Deborah A. +13 more·2020·Science Advances

Cited by (171)

Items 101–171 of 171

  1. A Huluwa phosphorylation switch regulates embryonic axis induction
    Yao Li, Yun Yan, Bo Gong, Qianwen Zheng, Hai-Yan Zhou, Jiarui Sun, Mingpeng Li, Zhao Wang, Yaohui Li, Yunjing Wan et al. · 2024 · Nature Communications
  2. Genetic of preimplantation diagnosis of dysmorphic facial features and intellectual developmental disorder (CHDFIDD) without congenital heart defects
    Xiangrong Cui, Xueqing Wu, Hongwei Wang, Sanyuan Zhang, Wei Wang, Xuan Jing · 2022 · Molecular Genetics & Genomic Medicine
  3. Tubular-specific CDK12 knockout causes a defect in urine concentration due to premature cleavage of the slc12a1 gene
    Bin Wang, Yao Wang, Yi Wen, Yilin Zhang, Wei‐Jie Ni, Tao‐Tao Tang, Jing-Yuan Cao, Qing Yin, Wei Jiang, Di Yin et al. · 2022 · Molecular Therapy
  4. Case Report: Hemophagocytic Lymphohistiocytosis Prior to the Onset of Leukemia in a Boy With CDK13-Related Disorder
    Dongyan Cui, Songmi Wang, Ai Zhang, Aiguo Liu, Qun Hu · 2022 · Frontiers in Genetics
  5. Cyclin‐dependent kinases as therapeutic targets in cancer: Recent advances, challenges, and opportunities
    Ning Ju, Li Zhao, Shanshan Yin, Xiangrui Yang, Jin Zhou, Jinmin Gao, Feifei Qi · 2026 · International Journal of Cancer
  6. CDK13 ‐Related Disorder: Novel Insights From A Series of 27 Cases and Recommendations for Clinical Management
    Gianluca Contrò, Maria Chiara Baroni, Stefano Giuseppe Caraffi, Manuela Napoli, Rosangela Artuso, Annarita Giliberti, Sara Bargiacchi, Giorgia Mancano, Giovanna Traficante, Mafalda Mucciolo et al. · 2025 · Clinical Genetics
  7. Discovery of 4-(2-(methylamino)thiazol-5-yl)pyrimidin-2-amine derivatives as novel cyclin-dependent kinase 12 (CDK12) inhibitors for the treatment of esophageal squamous cell carcinoma
    Yin Cao, Sen Huang, Yaohui He, Yuxiang Zhang, Simian Chen, Mengxian Huang, Fengming He, Shutong Chen, Lei Wang, Ziying Yang et al. · 2025 · Bioorganic Chemistry
  8. Organization and Dynamics of Transcription Elongation Foci in Mouse Tissues
    Chihiro Matsuda, Akane Ichiki, Yuko Sato, Yukino Kudo, Mika Saotome, Chihiro Takayama, Le Minh Khoa, Satoshi Uchino, Ryota Higuchi, Kazuhiko Kawata et al. · 2025 · Journal of Molecular Biology
  9. The Promoter-Proximal Pause: A Decision Point Governing RNA Polymerase II Fate
    Usman Hyder, David L. Bentley · 2026 · Annual Review of Biochemistry
  10. CDK12/CDK13 inhibition disrupts transcriptional elongation and replication fork progression in glioblastoma
    Silje Lier, Sara Markusson, Anja Kocijancic, Martine Narum, Solveig Osnes Lund, Bianka Böllering, Anuja Lipsa, M. Dige Soegaard, Idun Dale Rein, Petra Sántha et al. · 2026 · EMBO Molecular Medicine
  11. Tubule-specific cyclin-dependent kinase 12 knockdown potentiates kidney injury through transcriptional elongation defects
    Yilin Zhang, Tao‐Tao Tang, Wei‐Jie Ni, Zhong-Tang Li, Liang-Yun-Zi Jiang, Yao Wang, Xuan Zhou, Jing-Yuan Cao, Qing Yin, Wei Jiang et al. · 2024 · International Journal of Biological Sciences
  12. Molecular mechanisms of immune rejection against xenotransplantation in the pearl oyster Pinctada fucata revealed by serum proteomics
    Pei Wang, Ying Guo, Xiuxiu Sang, Tangrongjun Guo, Lipeng Yu, Tao Li, Yuewen Deng, Dahui Yu, Lirong Bai · 2024 · Aquaculture
  13. Cyclin-dependent kinases as mediators of aberrant transcription in prostate cancer
    Razia Rahman, Luke A. Selth · 2025 · Translational Oncology
  14. Dynamic O-GlcNAcylation and phosphorylation attract and expel proteins from RNA polymerase II to regulate mRNA maturation
    Aishwarya Gondane, Harri M. Itkonen · 2025 · Journal of Biomedical Science
  15. Gene Transcription as a Therapeutic Target in Leukemia
    Alvina I. Khamidullina, Ekaterina A. Varlamova, Nour Alhuda Hammoud, Margarita A. Yastrebova, Alexandra V. Bruter · 2021 · International Journal of Molecular Sciences
  16. Borrowing Transcriptional Kinases to Activate Apoptosis
    Roman C. Sarott, Sai P. Gourisankar, Basel A. Karim, Sabin A. Nettles, Haopeng Yang, Brendan G. Dwyer, Juste Simanauskaite, Jason Tse, Hind Z. Abuzaid, A. Krokhotin et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  17. Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
    Sander B. Frank, Thomas W. Persse, Ilsa Coleman, Armand Bankhead, Dapei Li, Navonil De Sarkar, Divin Wilson, Dmytro Rudoy, Manasvita Vashisth, Patty Galipeau et al. · 2024 · eLife
  18. Internal and external normalization of nascent RNA sequencing run-on experiments
    Zachary L. Maas, Robin D. Dowell · 2024 · BMC Bioinformatics
  19. CDK12 Is Necessary to Promote Epidermal Differentiation Through Transcription Elongation
    Jingting Li, Manisha Tiwari, Yifang Chen, Sudjit Luanpitpong, George L. Sen · 2022 · Stem Cells
  20. CAPTURE of the Human U2 snRNA Genes Expands the Repertoire of Associated Factors
    Joana Guiro, Mathias Fagbemi, Michael Tellier, Justyna Zaborowska, Stephanie Barker, Marjorie L. Fournier, Shona Murphy · 2022 · Biomolecules
  21. Advancements in chemical biology targeting the kinases and phosphatases of RNA polymerase II-mediated transcription
    Wantae Kim, Blase M. LeBlanc, Wendy L. Matthews, Zhong‐Yin Zhang, Yan Zhang · 2021 · Current Opinion in Chemical Biology
  22. Absence of CDK12 in oocyte leads to female infertility
    Denisa Jansová, Veronika Sedmikova, Fatima J. Berro, Daria Aleshkina, Michal Dvoran, Michal Kubelka, Jitka Rezacova, Jana Rutarova, Jiří Kohoutek, Andrej Šušor · 2025 · Cell Death and Disease
  23. Discovery of DN1679 as a Potent, Orally Bioavailable, and Highly Selective CDK12/13 Dual Degrader for the Treatment of Triple-Negative Breast Cancer
    Danni Chen, Jiawen Hu, Y. Shane Yu, Kailin Li, Tingting Wang, Zidong Wang, Yi Yuan, Xuejing Shao, Meidan Ying, Bo Yang et al. · 2025 · Journal of Medicinal Chemistry
  24. CDK12 and CDK13 in oncology: from RNA regulation to therapeutic targeting
    Julia Dudkiewicz-Garbicz, Pawel Krzysztof Wlodarski · 2026 · Cellular Oncology
  25. CPSF73 activation and 3′ RNA polymerase II pausing are lost during readthrough transcription after heat shock
    Kaitlyn E. Walsh, James A. Goodrich, Jennifer F. Kugel · 2026 · Cell Reports
  26. The Bidirectional Link Between RNA Cleavage and Polyadenylation and Genome Stability: Recent Insights From a Systematic Screen
    Stefano Spada, Brian Luke, Sven Danckwardt · 2022 · Frontiers in Genetics
  27. CDK12/13 inhibitor, CTX-439, suppresses tumor growth and potentiates BCL-2 family blockade
    Hiroko Yamakawa, Raghda Khatab, Akio Mizutani, Shunsuke Ebara, Takaharu Hirayama, Sunao Tanaka, Yusuke Tarumoto, Midori Sugiyama, Seiichi Sugino, Mariko Takano et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  28. Targeting CDK7/12/13 functional synergism reverses myofibroblast activation and ameliorates lung fibrosis
    Hsiao‐Yen Ma, Zhiyu Huang, Surinder Jeet, Claire Emerson, Hannah S. Bender, Qihao Ren, Ning Ding · 2025 · iScience
  29. UPF3B Accelerates the Growth of Liver Cancer Cells by Enhancing Autophagy via CDK12
    Sijie Xie, Shuting Song, Xinlei Liu, Dongdong Lu · 2025 · Cell Biology International
  30. Discovery of a Selective and Potent Inhibitor of Cyclin-Dependent Kinase 12/13 Employing a Noncovalent Mechanism
    Robert A. Swyka, Evan D. Styduhar, Anlai Wang, Xin Li, Ke Zhang, Michael R. Witten, Peng Zhao, Michael Z. Liang, Onur Atasoylu, Peng He et al. · 2026 · ACS Medicinal Chemistry Letters
  31. Cytoplasmic mRNA decay by the antiviral nuclease RNase L promotes transcriptional repression
    Xiaowen Mao, Sherzod A. Tokamov, Felix Pahmeier, Azra Lari, Jinyi Xu, Eva Harris, Britt A. Glaunsinger · 2026 · Cell Reports
  32. Alternative polyadenylation in cancer: mechanisms, functions, and therapeutic potential
    Yu Huang, Zhihong Li, Fenglei Yu, Lujuan Wang · 2026 · Molecular Cancer
  33. Human Genetics of Atrial Septal Defect
    Lars Allan Larsen, Marc‐Phillip Hitz · 2024 · Advances in experimental medicine and biology
  34. Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
    Sander B. Frank, Thomas W. Persse, Ilsa Coleman, Armand Bankhead, Dapei Li, Navonil De Sarkar, Divin Wilson, Dmytro Rudoy, Manasvita Vashisth, Patty Galipeau et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  35. Mitotic phosphorylation of ADAR1 regulates its centromeric localization and is required for faithful mitotic progression
    Yuxi Yang, Mai Kubota, Kokone Hasegawa, Chao Zeng, Kazuko Nishikura, Michiaki Hamada, Masayuki Sakurai · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  36. Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
    Sander B. Frank, Thomas W. Persse, Ilsa Coleman, Armand Bankhead, Dapei Li, Navonil De Sarkar, Divin Wilson, Dmytro Rudoy, Manasvita Vashisth, Patty Galipeau et al. · 2025 · eLife
  37. The PAF1 Complex Recruits Integrator to Chromatin Globally to Terminate Non-Productive Transcription
    Xinhong Liu, Ziwei Guo, Jing Han, Bin Zhang, Xiaoyu Hu, Charles J. David, Mo Chen · 2021 · SSRN Electronic Journal
  38. Age- or Lifestyle-Induced Accumulation of Genotoxicity Is Associated With a Generalized Shutdown of Long Gene Transcription
    Olga Ibáñez-Solé, Ander Izeta · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  39. Data from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
    Tiziana Monteverde, Sudhakar Sahoo, Manuela La Montagna, Peter Magee, Lei Shi, Dave Chi Hoo Lee, Robert Sellers, Alexander R. Baker, Hui Sun Leong, Matteo Fassan et al. · 2023
  40. Data from Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer
    Lin Cheng, Shichao Zhou, Shaoqing Zhou, Kaixuan Shi, Yan Cheng, Mei‐Chun Cai, Kaiyan Ye, Lifeng Lin, Zhenfeng Zhang, Chenqiang Jia et al. · 2023
  41. Tumor suppression by RNA surveillance
    Robert P. Fisher · 2023 · Science
  42. The spreading of facultative H3K9me3-heterochromatin drives congenital disease
    Chen Wang, Wei Zhang, Xuelin Chen, Wenfei Wang, Yong-Hao Li, Jian-Feng Chang, Xiao-Bo Guo, Yuanya Jing, Yabin Li, Xinyi Lu et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  43. Ubiquitylation of RNA Polymerase II Controls Early Stages of the Transcription Cycle
    Roberta Cacioppo, Alexander Gillis, Iván Shlamovitz, Andrew Zeller, Daniela Castiblanco, Alastair Crisp, Benjamin Haworth, Angela Arabiotorre, Pegah Abyaneh, Yu Bao et al. · 2024 · SSRN Electronic Journal
  44. A pathogenic missense variant, c.2149G>A (p.Gly717Arg), in CDK13 in a female patient with CDK13-related disorder: A case report and literature review of 112 cases
    Naoki Morooka, Jun Kido, Hiroe Ueno, Yohei Misumi, Keishin Sugawara, Shinichi Kameyama, Hiromi Fukuda, Takeshi Mizuguchi, Naomichi Matsumoto, Mitsuharu Ueda et al. · 2024 · Brain and Development Case Reports
  45. Acute BRCAness Induction and AR Signaling Blockage through CDK12/7/9 Degradation Enhances PARP Inhibitor Sensitivity in Prostate Cancer
    Fu Gui, Baishan Jiang, Jie Jiang, Zhixiang He, Takuya Tsujino, Tomoaki Takai, Seiji Arai, Celine Pana, Jens W. Köllermann, Gary Andrew Bradshaw et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
    Sander B. Frank, Thomas W. Persse, Ilsa Coleman, Armand Bankhead, Dapei Li, Navonil De Sarkar, Divin Wilson, Dmytro Rudoy, Manasvita Vashisth, Patty Galipeau et al. · 2024 · eLife
  47. Congenital Heart Defects, Dysmorphic Facial Features, and Intellectual Developmental Disorder (CHDFIDD)
    Asmae Akbari · 2025 · Springer eBooks
  48. (R)-6-[N-(3-(4-chlorophenyl) propyl] derivative of (R)-roscovitine inhibits lung carcinoma progression via cyclin-dependent kinase suppression
    Jie Guo, Jianshe Chen, Weijie Li, Jinwen Yang, Abdul Basit, Siwei Zhang, Shuojie Wang · 2025 · Bioorganic & Medicinal Chemistry
  49. Overexpression of CCNK Leads to Early Resumption of Meiosis in Mouse Oocytes
    Yuan‐Hong Xu, Simin Sun, Bin Zhao, Jia‐Ni Guo, Xue‐Mei Yang, Yi‐Ke Lu, Yina Zhang, Ding Ji, Zhen‐Bo Wang · 2025 · Molecular Reproduction and Development
  50. Additional file 3 of Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
    Eleonora Cesari, Alessandra Ciucci, Marco Pieraccioli, Cinzia Caggiano, Camilla Nero, Davide Bonvissuto, Francesca Sillano, Marianna Buttarelli, Alessia Piermattei, Matteo Loverro et al. · 2024 · Figshare
  51. Additional file 2 of Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
    Eleonora Cesari, Alessandra Ciucci, Marco Pieraccioli, Cinzia Caggiano, Camilla Nero, Davide Bonvissuto, Francesca Sillano, Marianna Buttarelli, Alessia Piermattei, Matteo Loverro et al. · 2024 · Figshare
  52. Additional file 1 of Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
    Eleonora Cesari, Alessandra Ciucci, Marco Pieraccioli, Cinzia Caggiano, Camilla Nero, Davide Bonvissuto, Francesca Sillano, Marianna Buttarelli, Alessia Piermattei, Matteo Loverro et al. · 2024 · Figshare
  53. Additional file 1 of Internal and external normalization of nascent RNA sequencing run-on experiments
    Zachary L. Maas, Robin D. Dowell · 2024 · Figshare
  54. Additional file 4 of Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
    Eleonora Cesari, Alessandra Ciucci, Marco Pieraccioli, Cinzia Caggiano, Camilla Nero, Davide Bonvissuto, Francesca Sillano, Marianna Buttarelli, Alessia Piermattei, Matteo Loverro et al. · 2024 · Figshare
  55. Additional file 2 of Internal and external normalization of nascent RNA sequencing run-on experiments
    Zachary L. Maas, Robin D. Dowell · 2024 · Figshare
  56. SF3B1 Phosphorylation Prompts U2AF2 Dissociation for Widespread Control of pre-mRNA Splicing
    Christopher L. Kirchhoff, Hannah R. Powell, Justin W. Galardi, Sarah Loerch, Mary J. Pulvino, Jermaine L. Jenkins, Paul L. Boutz, Clara L. Kielkopf · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  57. The RNA Editome of Esophageal Squamous Cell Carcinoma Identifies an ADAR1-CDK13 Editing Feedback Loop Mediating cGAS–STING Activation in Early Tumorigenesis
    Lihong Huang, Mingle Yang, D. Z. Li, Guozhong Jiang, Wenliang Zhang · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  58. Pre-mRNA 3'-end polyadenylation : impact on UV-induced DNA damage and on the translatability of immune-related genes
    Biswendu Biswas · 2022 · theses.fr (ABES)
  59. CDK12 and CDK13 suppress distinct intronic polyadenylation sites
    Molly J. Hulver, Andrew Polevoda, Kai-Lieh Huang, Eric J. Wagner, Paul L. Boutz · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  60. Cyclin K condensates bridge CDK12 to phosphorylate and drive oncogenic YAP activation in hepatocellular carcinoma
    Yang Sun, Yu Zhang, W W Yan, Jinlin Duan, Ke Qiao, Guoquan Yan, Junyan Xue, Jie Wang, Ming Zhan, Qi Li et al. · 2026 · Science Advances
  61. Termination dynamics set RNAPII elongation rate and gate the response to CDK12 inactivation
    Oliver Ozaydin, Lin Liu, Dáire Gannon, Mina Haddawi, Chloe A. N. Gerak, Sarahi Rivera, Laura Corso, Maede Salehi, Mengbo Li, Yining Tian et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  62. Mechanisms of transcription termination across the coding and noncoding loci of the genome
    Aixia Song, Minhui Hu, Fei Chen · 2026 · Nature Reviews Molecular Cell Biology
  63. Synthesis and antitumoral evaluation of 3′,4′-unsaturated nucleoside analogues bearing a chlorinated remdesivir-like base
    Song Wang, Jing Yang, Xinyue Yang, Hao Huang, Haiyang Zou, Yu Zhang, Xushan Zhang, Congcong Luo, Bing Zhao, Feng‐Wu Liu et al. · 2026 · Bioorganic Chemistry
  64. Cyclins and Cyclin‐Dependent Kinases: Structure, Biological Functions, and Innovative Targeting Strategies in Cancer
    Suya Zheng, Zhipeng Shen, Yuanfang Wu, Xingze Huang, Zhongyuan Zhang, Jiangyu Liu, Qichun Wei, Wenhao Chen, Ye Chen, Liang Xu · 2026 · MedComm
  65. Transcriptional kinases drive gene expression network plasticity
    David Daesung Lowe, Ali Shilatifard · 2026 · Molecular Cell
  66. Targeting CDKs in the RNAPII transcription cycle
    Robert P. Fisher, Matthias Geyer · 2026 · Nature Reviews Drug Discovery
  67. A guide to transcriptional cyclin‐dependent kinases in cancer
    Jennifer R. Devlin, Salla Kyheröinen, Ricky W. Johnstone · 2026 · FEBS Journal
  68. Pharmacologically targeting CDK12 induces BRCAness and synergizes with merestinib to exacerbate DNA damage in high-risk neuroblastoma
    Joshua Robert Goulding, Stijn Tim Couwenbergh, Sarah-Lee Bekaert, Ellen Sanders, Fanny De Vloed, Vicky Amo-Addae, Aline Eggermont, Jolien De Wyn, Kaat De Wever, Lasse Vleminckx et al. · 2026 · Cell Reports
  69. BindingDB Entry 50015218: Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitor.
    BindingDB · 2023 · UC San Diego
  70. BindingDB Entry 50016375: Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12 and CDK13.
    BindingDB · 2023 · UC San Diego
  71. BindingDB Entry 50015910: Current progress and novel strategies that target CDK12 for drug discovery.
    BindingDB · 2023 · UC San Diego